Menu Menu

ESLAW    Estrella Immunopharma Inc    1844417    
Income Statement
Net Income -3,376,737

Balance Sheet
Current Assets 2,235,145
Assets 3,735,145
Current Liabilities 2,988,859
Liabilities 2,988,859
Equity 746,286

Cash Flow Statement
Operating Cash Flow -2,217,460
Investing Cash Flow 4,960,647

Market Analysis
Market Cap 34,921,237
Price 0.09
FCF 2,743,187
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Find a discrepancy? The most accurate way to find company fundamental data is to view ESLAW documents filed with the SEC.


ESLAW Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: